Received May 28, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (VAQTA) | MERCK & CO. INC. | UNK | Y013274 | — |
No additional AE; HCP reported that improperly stored VAQTA was administered.; This spontaneous report has been received from an other health professional, regarding to a patient of unknown gender and age. The patient's pertinent medical history, concurrent conditions, concomitant medications, and previous drug reactions or allergies were not reported. On 23-MAY-2025, the patient was vaccinated with an improperly stored dose of with improperly storage dose of Hepatitis A Vaccine, Inactivated (VAQTA) suspension for injection, at a dose of 0.5 milliliter (ml), as prophylaxis, lot number Y013274 which was determined to be valid, with an expiration date on 26-DEC-2025(vaccination scheme, route of administration, and anatomical site of injection were not reported). Administered doses were stored at a temperature of 35.04 degrees Fahrenheit (F), during a time frame of 2 hours and 14 minutes (product storage error). No additional adverse events were reported in the patient.